NIH to bring iPS cell therapy into clinic for dry macular degeneration

Researchers at NIH's National Eye Institute (NEI) developed clinical-grade protocols for producing an autologous induced pluripotent stem cell-derived therapy for dry age-related macular degeneration. NEI plans

Read the full 261 word article

User Sign In